ISSN: 1080-6059
Hélène Marchandin,*† Estelle Jumas-Bilak,† Abderrahmane
Boumzebra,* Delphine Vidal,* Olivier Jonquet,* and Philippe Corne*‡ ![]()
*Centre Hospitalier Universitaire de Montpellier, Montpellier, France; †Unité de
Formation et de Recherche des Sciences Pharmaceutiques, Montpellier, France;
and ‡Institut de Recherche pour le Développement, Montpellier,
France
Suggested citation for this article
To the Editor: Streptococcus equi belongs to the pyogenic group of streptococci and to group C of the Lancefield classification. It consists of 3 subspecies of zoonotic agents rarely reported as human pathogens (1,2): S. equi subsp. equi, S. equi subsp. zooepidemicus, and S. equi subsp. ruminatorum. We report here a case of human infection caused by S. equi subsp. ruminatorum. (3).
A 53-year-old man was admitted to an intensive care unit of our hospital (University Teaching Hospital, Montpellier, France) on April 28, 2006, with a high fever and in a comatose state. The day before, he had experienced headache and neck pain. He had been infected with HIV for 9 years but had not had an opportunistic infection. His ongoing HIV treatment consisted of ritonavir, lopinavir, abacavir, lamivudine, and co-trimoxazole; 3 weeks before admission, his blood CD4+ T-cell count was 133/μL, and viral load was 118,000 copies/mL. At the time of admission, his body temperature was 38.9°C, heart rate was 105 beats/min, and blood pressure was 55/35 mmHg. He exhibited a fixed pupil in 1 eye, neck stiffness, and was nonresponsive. He had bilateral pulmonary infiltrates and severe hypoxemia. Treatment consisted of mechanical ventilation, fluid therapy, and norepinephrine. Laboratory investigations found the following: leukocyte count 9,600/mm3 with 90% neutrophils, hemoglobin level 9.0 g/dL, platelet count 32,000/mm3, C-reactive protein value 159 mg/L, and blood lactate concentration 3.2 mmol/L. Computed tomographic scanning of the brain showed no hemorrhage or edema. Lumbar puncture produced turbid cerebrospinal fluid (CSF) with 300 leukocytes/mm3 (95% neutrophils), protein 5.6 g/L, glucose <0.1 mmol/L, and gram-positive cocci. Three sets of aerobic-anaerobic blood cultures and bronchial aspirates were sampled, and intravenous treatment with dexamethasone (10 mg/6 h/day), cefotaxime (2 g/4 h/day), and vancomycin (30 mg/kg/day) was initiated. On day 2, the hemodynamic state was stabilized, but brain death occurred.
![]() |
Figure. Neighbor-joining tree showing the phylogenetic placement of strain ADV 6048.06 (boldface) among members of the Streptococcus equi species in the pyogenic group of streptococci... |
All sets of aero-anaerobic blood cultures, CSF, and bronchial aspirate fluid yielded the growth of a catalase-negative, β-hemolytic, gram-positive cocci belonging to the Lancefield group C of streptococci. Antimicrobial susceptibility testing showed a bacterium fully susceptible to antibiotics tested. MICs of penicillin, amoxicillin, and cefotaxime were 0.047, 0.125, and 0.125 mg/L, respectively. The isolates were identified as S. equi by using the Vitek2 system, rapid ID32 STREP, and API 20 STREP strips (bioMérieux, Marcy l'Etoile, France), but phenotype was inconclusive for subspecies identification. The strains were identified as S. equi subsp. zooepidemicus by Vitek2, but aesculin was not hydrolyzed, and D-ribose fermentation was noted, as previously described for S. equi subsp. ruminatorum. 16S rRNA gene–based identification was performed as previously described (4) on strain ADV 6048.06 from blood. The 1,396-bp sequence (GenBank accession no. EF362949) was compared with databases by using the BLAST program (5); the sequence differed by only 1 nucleotide position (>99.9% identity) from the sequence of S. equi subsp. ruminatorum CECT 5772T. Other primarily related sequences were from S. equi subsp. ruminatorum strains of animal origin (99.5%–99.9% identity) and from S. equi subsp. zooepidemicus, (98.7% identity). Phylogenetic trees clustered the clinical isolate with S. equi subsp. ruminatorum strains to form a robust lineage, well separated from other strains of S. equi and supported by a high bootstrap value (Figure).
S. equi subsp. equi and S. equi subsp. zooepidemicus are zoonotic agents implicated in diverse animal infections such as strangles, mastitis, abscesses, wounds, and respiratory and uterine infections. Human infections caused by S. equi subsp. equi, and S. equi subsp. zooepidemicus included outbreaks of foodborne diseases (6,7), meningitis, septicemia, arthritis, pneumonia, glomerulonephritis, and streptococcal toxic shock syndrome, in both immunocompromised and immunocompetent patients (1,2,8,9). S. equi subsp. ruminatorum was described in 2004 in domestic sheep and goats with mastitis (3). More recently, it was isolated during severe infections in spotted hyenas and zebras (10). No human isolate has been reported to date. Moreover, none of the 3 subspecies of S. equi has been isolated from HIV-infected patients. The current case underlines the conclusion that molecular identification of S. equi subsp. ruminatorum is essential. S. equi subsp. ruminatorum could have been underestimated due to its potential misidentification as S. equi subsp. zooepidemicus by phenotypic tools. Despite the rare occurrence of group C streptococci in human infections, a high death rate is reported for invasive infections (7–9). S. equi subsp. zooepidemicus produce superantigen exotoxin that may have been implicated in the pathogenesis of fatal infection (2); S. equi subsp. ruminatorum should also be investigated for potential virulence factors for humans.
Epidemiologic investigations were unsuccessful in tracing the patient's infection to an animal source. The respiratory tract, from which S. equi subsp. ruminatorum was recovered in pure culture, could be considered the most probable portal of entry.
The mode of S. equi subsp. ruminatorum transmission to humans remains unknown. More information is needed on its reservoirs, but they likely resemble those of S. equi subsp. equi, and S. equi subsp. zooepidemicus (2,6,7). Prevention of human infections due to S. equi should include frequent microbiologic sampling of lactating animals and control measures for unpasteurized dairy products (7). Better characterization of underlying conditions that increase risk of invasive S. equi infections is also needed. This knowledge could help define high-risk groups of persons and could lead to generation of specific preventive recommendations.
Marchandin H, Jumas-Bilak E, Boumzebra A, Vidal D, Jonquet O, Corne P. Fatal Streptococcus equi subsp. ruminatorum infection in a Man [letter]. Emerg Infect Dis [serial on the Internet]. 2007 Dec [date cited]. Available from http://www.cdc.gov/EID/13/12/1964.htm
Please use the form below to submit correspondence to the authors or contact them at the following address:
Philippe Corne, Service de Réanimation Médicale Assistance Respiratoire, Hôpital Gui de Chauliac, 80 Avenue Augustin Fliche, 34295 Montpellier CEDEX 5, France; email: p-corne@chu-montpellier.fr
Please contact the EID Editors at eideditor@cdc.gov
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
This page posted November 29, 2007
This page last reviewed November 29, 2007
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435